Recombinant Newcastle disease virus (NDV/Anh-IL-2) expressing human IL-2 as a potential candidate for suppresses growth of hepatoma therapy

Recombinant Newcastle disease virus (NDV/Anh-IL-2) expressing human IL-2 as a potential candidate for suppresses growth of hepatoma therapy

Newcastle disease virus (NDV) have shown oncolytic therapeutic efficacy in preclinical study and are currently approved for clinical trials. NDV Anhinga strain which is a mesogenic strain should be classified as lytic strain and has a therapeutic efficacy in hepatocellular cancer. In this study, we...

Full description

Bibliographic Details
Main Authors: Yunzhou Wu, Jinjiao He, Ying An, Xi Wang, Yunye Liu, Shijun Yan, Xianlong Ye, Jianying Qi, Shenglong Zhu, Qingzhong Yu, Jiechao Yin, Deshan Li, Wenfei Wang
Format: Article
Language:English
Published: Elsevier 2016-09-01
Series:Journal of Pharmacological Sciences
Subjects:
Newcastle disease virus
Oncolysis
Hepatoma
Hepatocellular carcinoma
IL-2
Online Access:http://www.sciencedirect.com/science/article/pii/S1347861316300068

Internet

http://www.sciencedirect.com/science/article/pii/S1347861316300068

Similar Items